Serveur d'exploration MERS - Exploration (Accueil)

Index « Teeft.i » - entrée « Hepatitis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hepatic uptake < Hepatitis < Hepatitis agent  Facettes :

List of bibliographic references indexed by Hepatitis

Number of relevant bibliographic references: 53.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
002094 (2013) Susan L. Stramer ; Roger Y. DoddTransfusion‐transmitted emerging infectious diseases: 30 years of challenges and progress
002323 (2012) Shizhen Qin [États-Unis] ; Yong Zhou [États-Unis] ; Anna S. Lok [États-Unis] ; Alex Tsodikov [États-Unis] ; Xiaowei Yan [États-Unis] ; Li Gray [États-Unis] ; Min Yuan [États-Unis] ; Robert L. Moritz [États-Unis] ; David Galas [États-Unis] ; Gilbert S. Omenn [États-Unis] ; Leroy Hood [États-Unis]SRM targeted proteomics in search for biomarkers of HCV‐induced progression of fibrosis to cirrhosis in HALT‐C patients
002368 (2012) Yonghong Zhang [République populaire de Chine] ; Yali Liu [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Lingxian Shi [République populaire de Chine] ; Lina Ma [République populaire de Chine] ; Huiping Yan [République populaire de Chine] ; Hao Wu [République populaire de Chine] ; Lai Wei [République populaire de Chine] ; Tao Dong [Royaume-Uni] ; Xinyue Chen [République populaire de Chine]Hepatitis C virus nonstructural protein specific T cells are associated with virological responses to combination therapy in chronic HCV patients
002375 (2012) Leonhard Stross [Allemagne] ; Johannes Günther [Allemagne] ; Georg Gasteiger [Allemagne, États-Unis] ; Theresa Asen [Allemagne] ; Stefanie Graf [Allemagne] ; Michaela Aichler [Allemagne] ; Irene Esposito [Allemagne] ; Dirk H. Busch [Allemagne] ; Percy Knolle [Allemagne] ; Tim Sparwasser [Allemagne] ; Ulrike Protzer [Allemagne]Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice
002597 (2011) Vito Racanelli [Italie, États-Unis] ; Patrizia Leone [Italie] ; Arash Grakoui [États-Unis, Italie]A spatial view of the CD8+ T‐cell response: the case of HCV
003161 (2004) Jae-Kyoung Shim ; Young-Choon Lee ; Tae-Ho Chung [Corée du Sud] ; Cheorl-Ho Kim [Corée du Sud]Elevated expression of bisecting N‐acetylglucosaminyltransferase‐III gene in a human fetal hepatocyte cell line by hepatitis B virus
003174 (2004) Colette Jolivet-Reynaud [France] ; Anne Adida [France] ; Sandrine Michel [France] ; Gilbert Deléage [France] ; Glaucia Paranhos-Baccala [France] ; Virginie Gonin [France] ; Nicole Battail-Poirot [France] ; Xavier Lacoux [France] ; Dominique Rolland [France]Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase
003294 (2003) Yasunari Nakamoto [Japon] ; Shuichi Kaneko [Japon] ; Hisao Takizawa [Japon] ; Yoshikazu Kikumoto [Japon] ; Masaaki Takano [Japon] ; Yoshiko Himeda [Japon] ; Kenichi Kobayashi [Japon]Analysis of the CD8‐positive T cell response in Japanese patients with chronic hepatitis C using HLA‐A*2402 peptide tetramers
003390 (2002) L. V. Olenina ; L. I. Nikolaeva ; B. N. Sobolev ; N. P. Blokhina [Russie] ; A. I. Archakov ; E. F. KolesanovaMapping and characterization of B cell linear epitopes in the conservative regions of hepatitis C virus envelope glycoproteins
003492 (2001) Treatment of chronic hepatitic C with inteferon-alfa-2B and ribavirin in decompensated cirrhotics listed for transplant - a retrospective study
003493 (2001) Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients
003516 (2001) Sandra Hjalmarsson [Suède, États-Unis] ; Jonas Blomberg [Suède] ; Lena Grillner [Suède] ; Rüdiger Pipkorn [Suède] ; Tobias Allander [Suède, États-Unis]Sequence evolution and cross‐reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection
003543 (2001) Colette Jolivet-Reynaud [France] ; Mylène Lésenéchal [France] ; Barbara O'Donnell [Royaume-Uni] ; Laurence Becquart [France] ; Agnès Foussadier [France] ; Françoise Forge [France] ; Nicole Battail-Poirot [France] ; Xavier Lacoux [France] ; William Carman [Royaume-Uni] ; Michel Jolivet [France]Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti‐hepatitis B surface antigen monoclonal antibodies
003579 (2001) DNA immunization for identification and localization of antigenic regions on duck hepatitis B virus core protein
003589 (2001) Pablo Sarobe [Espagne] ; Eduardo Huarte [Espagne] ; Juan José Lasarte [Espagne] ; Ascensi N L Pez-D Az De Cerio [Espagne] ; Nicolás Garc A [Espagne] ; Francisco Borrás-Cuesta [Espagne] ; Jesús Prieto [Espagne]Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes
003596 (2001) R. A Heijtink [Pays-Bas] ; P. Van Bergen [Pays-Bas] ; M. H Van Roosmalen [Pays-Bas] ; C. M. G Sünnen [Pays-Bas] ; W. P Paulij [Pays-Bas] ; S. W Schalm [Pays-Bas] ; A. D. M. E Osterhaus [Pays-Bas]Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg
003601 (2001) Additional lamivudine therapy after HBeAg seroconversion would prolong the durability of response in HBV endemic area
003646 (2000) Alexander Y. Lee [États-Unis] ; Noelle K. Polakos [États-Unis] ; Gillis R. Otten [États-Unis] ; Jeffrey B. Ulmer [États-Unis] ; Michael Houghton [États-Unis] ; Xavier Paliard [États-Unis]Quantification of the number of cytotoxic T cells specific for an immunodominant HCV-specific CTL epitope primed by DNA immunization
003671 (2000) Xavier Forns ; Paul J. Payette ; Xiaoying Ma ; William Satterfield ; Gerald Eder ; Isa K. Mushahwar ; Sugantha Govindarajan ; Heather L. Davis ; Suzanne U. Emerson ; Robert H. Purcell ; Jens BukhVaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV
003848 (1999) Andree Zibert [Allemagne] ; Wolfgang Kraas [Allemagne] ; R. Stefan Ross [Allemagne] ; Helga Meisel [Allemagne] ; Sabine Lechner [Allemagne] ; Günther Jung [Allemagne] ; Michael Roggendorf [Allemagne]Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection
003852 (1999) Kyong-Mi Chang [États-Unis] ; Francis V. ChisariIMMUNOPATHOGENESIS OF HEPATITIS B VIRUS INFECTION

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Hepatitis" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Hepatitis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Hepatitis
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021